Literature DB >> 9415326

Oral leukoplakia: a clinicopathological review.

I van der Waal1, K P Schepman, E H van der Meij, L E Smeele.   

Abstract

Leukoplakia is the most common premalignant or potentially malignant lesion of the oral mucosa. It seems preferable to use the term leukoplakia as a clinical term only. When a biopsy is taken, the term leukoplakia should be replaced by the diagnosis obtained histologically. The annual percentage of malignant transformation varies in different parts of the world, probably as a result of differences in tobacco and dietary habits. Although epithelial dysplasia is an important predictive factor of malignant transformation, it should be realized that not all dysplastic lesions will become malignant. On the other hand non-dysplastic lesions may become malignant as well. In some parts of the world the tongue and the floor of the mouth can be considered to be high-risk sites with regard to malignant transformation of leukoplakia, while this does not have to be the case in other parts of the world. The cessation of tobacco habits, being the most common known aetiological factor of oral leukoplakia, has been shown to be an effective measure with regard to the incidence of leukoplakia and, thereby, the incidence of oral cancer as well. Screening for oral precancer may be indicated in individuals at risk.

Entities:  

Mesh:

Year:  1997        PMID: 9415326     DOI: 10.1016/s1368-8375(97)00002-x

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  52 in total

1.  Marked variation in malignant transformation rates of oral leukoplakia.

Authors:  Aisling Anderson; Nurul Ishak
Journal:  Evid Based Dent       Date:  2015-12

Review 2.  Paan and Gutka in the United States: an emerging threat.

Authors:  Jyotsna Changrani; Francesca Gany
Journal:  J Immigr Health       Date:  2005-04

Review 3.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

4.  Alterations of Plasma lipid profile patterns in oral leukoplakia.

Authors:  N Mahesh; S A K Uroof Rahamthullah; Guntipalli M Naidu; Amudala Rajesh; P Ravisekhar Babu; J Muralinath Reddy
Journal:  J Int Oral Health       Date:  2014-02-26

5.  Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.

Authors:  Jau-Song Yu; Yi-Ting Chen; Wei-Fan Chiang; Yung-Chin Hsiao; Lichieh Julie Chu; Lai-Chu See; Chi-Sheng Wu; Hui-Tzu Tu; Hsiao-Wei Chen; Chia-Chun Chen; Wei-Chao Liao; Ya-Ting Chang; Chih-Ching Wu; Che-Yi Lin; Shyun-Yeu Liu; Shu-Ti Chiou; Shu-Li Chia; Kai-Ping Chang; Chih-Yen Chien; Su-Wei Chang; Chee-Jen Chang; John D Young; Chia C Pao; Yu-Sun Chang; Leland H Hartwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

6.  Oral leukoplakia in China: a review.

Authors:  Xiaolin Zhang; Chengjie Li; Yi Song; Peter A Reichart
Journal:  Oral Maxillofac Surg       Date:  2010-12

7.  Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.

Authors:  Yung-Chin Hsiao; Lang-Ming Chi; Kun-Yi Chien; Wei-Fan Chiang; Szu-Fan Chen; Yao-Ning Chuang; Shih-Yu Lin; Chia-Chun Wu; Ya-Ting Chang; Lichieh Julie Chu; Yi-Ting Chen; Shu-Li Chia; Chih-Yen Chien; Kai-Ping Chang; Yu-Sun Chang; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2017-08-18       Impact factor: 5.911

8.  Correlation analysis of oral lesion sizes by various standardized criteria.

Authors:  Carrie E Flanagan; Nelson L Rhodus; Kate A Cole; Eva Szabo; Frank G Ondrey
Journal:  Am J Otolaryngol       Date:  2016-07-12       Impact factor: 1.808

9.  A review of the nonsurgical treatment of oral leukoplakia.

Authors:  Adriana Spinola Ribeiro; Patrícia Ribeiro Salles; Tarcília Aparecida da Silva; Ricardo Alves Mesquita
Journal:  Int J Dent       Date:  2010-02-23

10.  Peroxiredoxin 1 has an anti-apoptotic role via apoptosis signal-regulating kinase 1 and p38 activation in mouse models with oral precancerous lesions.

Authors:  Jianfei Zhang; Xinying Jing; Wenwen Niu; Min Zhang; Lihua Ge; Congcong Miao; Xiaofei Tang
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.